Germany's Bayer secures U.S. FDA approval for hemophilia A therapy

(Reuters) - The U.S. Food and Drug Administration approved Bayer AG's therapy for the most common form hemophilia, the company said on Thursday, about three weeks after the treatment was cleared for use in Europe.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news